Page last updated: 2024-10-24

CD8-positive, alpha-beta T cell activation

Definition

Target type: biologicalprocess

The change in morphology and behavior of a CD8-positive, alpha-beta T cell resulting from exposure to a mitogen, cytokine, chemokine, cellular ligand, or an antigen for which it is specific. [CL:0000625, GOC:yaf]

CD8-positive, alpha-beta T cell activation is a complex process that involves the recognition of antigen presented by MHC class I molecules on antigen-presenting cells (APCs), leading to a cascade of signaling events that culminate in T cell proliferation, differentiation, and effector function. The process can be broadly divided into three phases: antigen recognition, signaling, and effector function.

**Antigen Recognition:**

1. **MHC-I Presentation:** APCs, such as dendritic cells, macrophages, and B cells, process and present antigen-derived peptides on MHC class I molecules. These peptides are derived from intracellular proteins, including viral proteins, tumor-associated antigens, and self-proteins.
2. **TCR Engagement:** CD8+ T cells express T cell receptors (TCRs) on their surface. These TCRs are highly specific for particular peptide-MHC class I complexes. When a CD8+ T cell encounters an APC displaying its cognate antigen, the TCR binds to the peptide-MHC complex, initiating the activation process.
3. **Costimulatory Signals:** Activation of CD8+ T cells requires not only TCR engagement but also costimulatory signals. These signals are provided by interactions between molecules on the T cell surface, such as CD28, and their ligands on APCs, such as CD80 and CD86. These costimulatory signals ensure that T cells are activated only in the presence of a genuine threat and prevent inappropriate activation.

**Signaling:**

1. **TCR Signaling Cascade:** TCR engagement triggers a cascade of intracellular signaling events. The TCR is associated with a complex of signaling molecules, including CD3, ζ-chain, and the tyrosine kinases Lck and Fyn. Upon TCR engagement, Lck phosphorylates the immunoreceptor tyrosine-based activation motifs (ITAMs) in the CD3 and ζ-chain.
2. **Activation of ZAP-70:** Phosphorylated ITAMs recruit and activate the tyrosine kinase ZAP-70. ZAP-70 then phosphorylates other signaling molecules, including the adaptor protein LAT.
3. **Downstream Signaling:** Phosphorylated LAT serves as a scaffold for the assembly of signaling complexes. These complexes involve various signaling molecules, such as PLCγ1, PI3K, and Ras, which activate downstream pathways, leading to the production of second messengers, such as calcium and diacylglycerol (DAG).

**Effector Function:**

1. **T Cell Proliferation and Differentiation:** The signaling events triggered by TCR engagement lead to the activation of transcription factors, such as NF-κB, NFAT, and AP-1. These transcription factors promote the expression of genes involved in T cell proliferation, survival, and differentiation.
2. **Effector T Cell Development:** Activated CD8+ T cells differentiate into cytotoxic T lymphocytes (CTLs). CTLs are equipped with cytotoxic granules containing perforin and granzyme, which can induce apoptosis in target cells.
3. **Immune Surveillance and Response:** CTLs patrol the body, recognizing and eliminating cells displaying their cognate antigen. This process is essential for the control of viral infections, elimination of tumor cells, and the maintenance of immune homeostasis.

**Note:** CD8-positive, alpha-beta T cell activation is a complex and tightly regulated process. Dysregulation of this process can contribute to autoimmune diseases and cancer. The precise mechanisms of CD8+ T cell activation can vary depending on the specific antigen and APC involved.

This detailed description provides a comprehensive overview of the biological process of CD8-positive, alpha-beta T cell activation, incorporating the various stages, signaling pathways, and effector functions.'"

Proteins (1)

ProteinDefinitionTaxonomy
HLA class I histocompatibility antigen, A alpha chain An MHC class I histocompatibility antigen A alpha chain that is encoded in the genome of human. [PRO:DAN]Homo sapiens (human)

Compounds (8)

CompoundDefinitionClassesRoles
astemizoleastemizole : A piperidine compound having a 2-(4-methoxyphenyl)ethyl group at the 1-position and an N-[(4-fluorobenzyl)benzimidazol-2-yl]amino group at the 4-position.

Astemizole: Antihistamine drug now withdrawn from the market in many countries because of rare but potentially fatal side effects.
benzimidazoles;
piperidines
anti-allergic agent;
anticoronaviral agent;
H1-receptor antagonist
haloperidolhaloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.

Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol
antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist
spiperonespiperone : An azaspiro compound that is 1,3,8-triazaspiro[4.5]decane which is substituted at positions 1, 4, and 8 by phenyl, oxo, and 4-(p-fluorophenyl)-4-oxobutyl groups, respectively.

Spiperone: A spiro butyrophenone analog similar to HALOPERIDOL and other related compounds. It has been recommended in the treatment of SCHIZOPHRENIA.
aromatic ketone;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound
alpha-adrenergic antagonist;
antipsychotic agent;
dopaminergic antagonist;
psychotropic drug;
serotonergic antagonist
raloxifene hydrochlorideraloxifene hydrochloride : A hydrochloride salt resulting from the reaction of equimolar amounts of raloxifene and hydrogen chloride.

Raloxifene Hydrochloride: A second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.
hydrochloridebone density conservation agent;
estrogen antagonist;
estrogen receptor modulator
trazodone hydrochloridetrazodone hydrochloride : A hydrochloride salt prepared from equimolar amounts of trazodone and hydrogen chloride.

Triticum: A plant genus of the family POACEAE that is the source of EDIBLE GRAIN. A hybrid with rye (SECALE CEREALE) is called TRITICALE. The seed is ground into FLOUR and used to make BREAD, and is the source of WHEAT GERM AGGLUTININS.
hydrochlorideadrenergic antagonist;
antidepressant;
H1-receptor antagonist;
sedative;
serotonin uptake inhibitor
doxazosin mesylateCardura: Trade name in United States.methanesulfonate saltgeroprotector
vatalanibmonochlorobenzenes;
phthalazines;
pyridines;
secondary amino compound
angiogenesis inhibitor;
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor;
vascular endothelial growth factor receptor antagonist
mart-1 antigenMART-1 Antigen: A melanosome-specific protein that plays a role in the expression, stability, trafficking, and processing of GP100 MELANOMA ANTIGEN, which is critical to the formation of Stage II MELANOSOMES. The protein is used as an antigen marker for MELANOMA cells.